Into the twilight zone – should ER-low breast cancer be treated as triple negative breast cancer?

• Helena Jernström,
• Lisa Rydén

Affiliations

Helena Jernström

Department of Clinical Sciences Lund, Oncology, Lund University, Lund, Sweden; Lund University Cancer Centre (LUCC) and Skåne University Hospital Comprehensive Cancer Center (SUHCC), Sweden; Corresponding author. Department of Clinical Sciences Lund, Oncology, Lund University, Barngatan 4, SE-221 85, Lund, Sweden.

Lisa Rydén

Lund University Cancer Centre (LUCC) and Skåne University Hospital Comprehensive Cancer Center (SUHCC), Sweden; Department of Clinical Sciences Lund, Surgery, Lund University and Skåne University Hospital, Lund, Sweden